← All trials
NCT04530539
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 18, 2020
- Primary completion
- Sep 1, 2021
- Completion date
- Dec 1, 2021
- First posted
- Aug 28, 2020
- Last posted
- Sep 16, 2020
- Enrollment
- 150
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Lancaster General HospitalLead sponsor
- Bay Area Retina AssociatesOverall official - principal investigator
- University of PennsylvaniaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.